CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ALK-Abello A/S is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ALK-Abello A/S
Boege Alle 6-8
Phone: +45 45747576p:+45 45747576 HOERSHOLM, 2970  Denmark Ticker: ALK BALK B

Business Summary
ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The Company operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board AndersHedegaard 64 3/11/2020 11/1/2007
President, Chief Executive Officer PeterHalling 47 1/1/2024 1/1/2024
Vice Chairman of the Board LeneSkole-Soerensen 64 3/12/2015 3/12/2014
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Alk Abello Inc 7806 Solution Center Chicago IL
Crystal Laboratory LLC 18600 East State Highway 66 Luther OK United States
Allergy Laboratories, Inc. 1005 SW 2nd Street Oklahoma City OK United States

Business Names
Business Name
0OIR
AKABY
Alk Abello Inc
8 additional Business Names available in full report.

General Information
Number of Employees: 2,824 (As of 12/31/2023)
Outstanding Shares: 221,189,247 (As of 12/31/2023)
Shareholders: 39,766
Stock Exchange: CPH
Fax Number: +45 45748690


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 18, 2024